Ann: Medlab Presenting at Jefferies Global Healthcare Conference, page-2

Mdc market capital is now down to $55million, almost down there with CannGlobal's fantastic management and research.
Mxc market capital is $130million due to the better research it has and management board it has.
MDC as a company can't compete with MXC by the looks of things.
Nanabis can't compete with Mxc's Artermic product?

How many more cents will MDC be sold down, and to what value? Same as CannGlobal?

Since when did Medlab become on the same level as CannGlobal and worth 3 times less than MXC?